Extrait

- Determination of systemic exposure of catumaxomab during and after four intraperitoneal infusions with increasing doses - Characterization of pharmacokinetics of catumaxomab after the second, the third and the fourth intraperitoneal infusion

Critère d'inclusion

• epithelial cell adhesion molecule (EpCAM) expressing tumors in patients with malignant ascites requiring therapeutic ascites puncture

Liens

• ictrp
• euctr